期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 124, 期 2, 页码 466-472出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI70050
关键词
-
资金
- NIH [T32DK007751, AR06394, DK 057501]
During bone resorption, abundant factors previously buried in the bone matrix are released into the bone marrow microenvironment, which results in recruitment and differentiation of bone marrow mesenchymal stem cells (MSCs) for subsequent bone formation, temporally and spatially coupling bone remodeling. Parathyroid hormone (PTH) orchestrates the signaling of many pathways that direct MSC fate. The spatiotemporal release and activation of matrix TGF-beta during osteoclast bone resorption recruits MSCs to bone-resorptive sites. Dysregulation of TGF-beta alters MSC fate, uncoupling bone remodeling and causing skeletal disorders. Modulation of TGF-beta or PTH signaling may reestablish coupled bone remodeling and be a potential therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据